0 01/07/2023 30/06/2024 2024-06-30 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-07-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 12426313 2023-07-01 2024-06-30 12426313 2024-06-30 12426313 2023-06-30 12426313 2022-07-01 2023-06-30 12426313 2023-06-30 12426313 2022-06-30 12426313 bus:RegisteredOffice 2023-07-01 2024-06-30 12426313 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 12426313 bus:Director1 2023-07-01 2024-06-30 12426313 bus:Director2 2023-07-01 2024-06-30 12426313 core:WithinOneYear 2024-06-30 12426313 bus:Director2 2024-06-30 12426313 bus:Micro-entities 2023-07-01 2024-06-30 12426313 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 12426313 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 12426313 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12426313 bus:FullAccounts 2023-07-01 2024-06-30
Company registration number: 12426313
Illuminare Medical Education Ltd
Unaudited filleted financial statements
30 June 2024
Illuminare Medical Education Ltd
Contents
Directors and other information
Accountant's report
Statement of financial position and notes to the financial statements
Illuminare Medical Education Ltd
Directors and other information
Directors Mr A J Birchett
Mr S Smith
Company number 12426313
Registered office 20-22 Wenlock Road
London
N1 7GU
Business address 3 Celadon Drive
Abbots Oak
Coalville
Leicestershire
LE67 4UH
Accountant J Robins Accountants
First Floor
59-63 Wood Street
Earl Shilton
Leicestershire
LE9 7NE
Bankers Barclays Bank plc
Leicester Town Hall Square
Leicester
LE87 2BD
Illuminare Medical Education Ltd
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Illuminare Medical Education Ltd
Year ended 30 June 2024
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 30 June 2024 which comprise the statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
J Robins Accountants
Chartered Certified Accountant
First Floor
59-63 Wood Street
Earl Shilton
Leicestershire
LE9 7NE
1 November 2024
Illuminare Medical Education Ltd
Statement of financial position
30 June 2024
2024 2023
£ £
Called up share capital not paid - 2
_______ _______
Current assets 15,854 -
Creditors: amounts falling due within one year ( 11,297) -
_______ _______
Net current assets/(liabilities) 4,557 -
_______ _______
Total assets less current liabilities 4,557 2
Accruals and deferred income ( 960) -
_______ _______
Net assets 3,597 2
_______ _______
Capital and reserves 3,597 2
_______ _______
Notes to the financial statements
Illuminare Medical Education Ltd
Year ended 30 June 2024
1. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Mr S Smith - ( 10,454) ( 10,454)
_______ _______ _______
2023
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Mr S Smith - - -
_______ _______ _______
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 01 November 2024 , and are signed on behalf of the board by:
Mr S Smith
Director
Company registration number: 12426313
The company is a private company limited by shares, registered in England.